Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 3
1990 3
1991 4
1992 1
1994 1
1995 2
1998 1
1999 1
2000 2
2001 1
2002 3
2003 2
2004 3
2005 3
2006 2
2007 1
2008 2
2012 1
2013 2
2014 2
2015 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
The reversal of inhibitors in congenital hemophilia.
DeFrates SR, McDonagh KT, Adams VR. DeFrates SR, et al. Among authors: mcdonagh kt. Pharmacotherapy. 2013 Feb;33(2):157-64. doi: 10.1002/phar.1173. Epub 2013 Jan 25. Pharmacotherapy. 2013. PMID: 23355059 Review.
Gene transfer into hematopoietic stem cells.
Nienhuis AW, McDonagh KT, Bodine DM. Nienhuis AW, et al. Among authors: mcdonagh kt. Cancer. 1991 May 15;67(10 Suppl):2700-4. doi: 10.1002/1097-0142(19910515)67:10+<2700::aid-cncr2820671705>3.0.co;2-3. Cancer. 1991. PMID: 2015571 Review.
Gene therapy in tissue-engineered blood vessels.
Fields RC, Solan A, McDonagh KT, Niklason LE, Lawson JH. Fields RC, et al. Among authors: mcdonagh kt. Tissue Eng. 2003 Dec;9(6):1281-7. doi: 10.1089/10763270360728198. Tissue Eng. 2003. PMID: 14670116 Free article.
High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes.
McSweeney PA, Nash RA, Sullivan KM, Storek J, Crofford LJ, Dansey R, Mayes MD, McDonagh KT, Nelson JL, Gooley TA, Holmberg LA, Chen CS, Wener MH, Ryan K, Sunderhaus J, Russell K, Rambharose J, Storb R, Furst DE. McSweeney PA, et al. Among authors: mcdonagh kt. Blood. 2002 Sep 1;100(5):1602-10. Blood. 2002. PMID: 12176878 Free PMC article. Clinical Trial.
Phase I study of the novel Cdc2/CDK1 and AKT inhibitor terameprocol in patients with advanced leukemias.
Tibes R, McDonagh KT, Lekakis L, Bogenberger JM, Kim S, Frazer N, Mohrland S, Bassett D, Garcia R, Schroeder K, Shanmugam V, Carpten J, Hagelstrom RT, Beaudry C, Von Hoff D, Shea TC. Tibes R, et al. Among authors: mcdonagh kt. Invest New Drugs. 2015 Apr;33(2):389-96. doi: 10.1007/s10637-014-0198-y. Epub 2014 Dec 19. Invest New Drugs. 2015. PMID: 25523151 Clinical Trial.
Phase I study of MLN8237--investigational Aurora A kinase inhibitor--in relapsed/refractory multiple myeloma, non-Hodgkin lymphoma and chronic lymphocytic leukemia.
Kelly KR, Shea TC, Goy A, Berdeja JG, Reeder CB, McDonagh KT, Zhou X, Danaee H, Liu H, Ecsedy JA, Niu H, Benaim E, Iyer SP. Kelly KR, et al. Among authors: mcdonagh kt. Invest New Drugs. 2014 Jun;32(3):489-99. doi: 10.1007/s10637-013-0050-9. Epub 2013 Dec 20. Invest New Drugs. 2014. PMID: 24352795 Free PMC article. Clinical Trial.
40 results